Haiyan Zhu

Dr. Haiyan Zhu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
SBSukhvir Kaur Bhangu
Sukhvir Kaur Bhangu
ANSHUL BARALANSHUL BARAL
ANSHUL BARAL
HZHaiyan Zhu
Haiyan Zhu
Muthupandian AshokkumarMuthupandian Ashokkumar
Muthupandian Ashokkumar
Francesca CavalieriFrancesca Cavalieri
Francesca Cavalieri
Low and high frequency ultrasonic techniques offer a green strategy to synthesize multifunctional nanoparticles from small aromatic biological molecules and proteins with tunable size, morphology, and optical and bio-functional properties.

2 September 2023 in Materials Advances
Verified
Journal Article
Open access
PDF file
ANSHUL BARALANSHUL BARAL
ANSHUL BARAL
HZHaiyan Zhu
Haiyan Zhu
BMBradford A. Moffat
Bradford A. Moffat
SCSantanu Chattopadhyay
Santanu Chattopadhyay
Francesca CavalieriFrancesca Cavalieri
Francesca Cavalieri
Muthupandian AshokkumarMuthupandian Ashokkumar
Muthupandian Ashokkumar
A facile sonochemical method to fabricate magnetic tryptophan-iron oxide nanoparticles for biomedical applications.

22 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
HZHaiyan Zhu
Haiyan Zhu
SBSukhvir Kaur Bhangu
Sukhvir Kaur Bhangu
Muthupandian AshokkumarMuthupandian Ashokkumar
Muthupandian Ashokkumar
Francesca CavalieriFrancesca Cavalieri
Francesca Cavalieri
Ultrasound-based engineering of carrier-free nanodrugs by supramolecular self-assembly has recently emerged as an innovative and environmentally friendly synthetic approach. By applying high-frequency sound waves (490 kHz) in aqueous solutions, the transformation of small chemotherapeutic and antibiotic drug molecules into carrier-free nanodrugs with anticancer and antimicrobial activities was recently achieved. The transformation of the antibiotic drug molecules, i.e., doxycycline, into stable nanodrugs (~130 nm) with selective anticancer activity was achieved without requiring organic solvents, chemical agents, or surfactants. The obtained nanodrug exhibited reactive oxygen species (ROS)-mediated cytotoxicity on human breast cancer (MDA-MB 231 cells) but a negligible antiproliferative effect on healthy fibroblast cells. Imaging by super-resolution microscopy (STORM) provided insights into the intracellular trafficking and endosomal escape of the nanodrugs. Overall, these findings suggest that small antibiotic drugs can be transformed into chemotherapeutic nanodrugs with high selectivity against cancer cells.